Dr. Saul Helman is a Managing Director at Navigant and is Life Sciences Practice leader. He provides support in investigations, litigation and compliance integration matters involving healthcare and life sciences companies. Applying his knowledge, secured through working in international marketing and clinical development in industry, Saul has led projects involving expert witness testimony, litigation support, compliance implementation and assessment and investigation support. He has led the support of clients and external counsel with investigations of fraud and abuse in industry.
Saul’s experience includes the development and implementation of global healthcare compliance programs, support of clients through Deferred Prosecution Agreements and Corporate Integrity Agreements, Pre-IRO support, Board and Executive level support through compliance program implementation or evaluation, auditing and monitoring of healthcare compliance programs, support of outside counsel through complex litigation matters including off-label promotion, clinical data management and disclosure, fraud and abuse (False Claims Act, Anti-Kickback Statute and Foreign Corrupt Practices Act) and aggregate spend reporting (Physician Payment Sunshine Act). In addition Saul has conducted risk assessments and remediation of manufacturing, regulatory, clinical, marketing and sales departments.
Saul's experience spans over two decades in life sciences, both in management and consulting roles. He also has significant international experience in healthcare, bio-pharmaceutical and medical device companies.
M.D. (MBBCh), University of the Witwatersrand M.B.A., Oxford Brookes University B.Sc., University of the Witwatersrand